Nexalin Highlights its Expanding Body of Peer-Reviewed Neuroimaging Research Confirming its DIFS™ Technology as the Leader in Evidenced-Based Non-Invasive Br…

Nexalin’s growing body of published data consistently demonstrates objective normalization of abnormal brain activity and ...
Hosted on MSN

Abnormal brain rhythms may offer new insight into Alzheimer’s disease and its link to epilepsy

A new study published in Brain Communications has uncovered abnormal brain wave activity in individuals with Alzheimer’s disease, suggesting a potential new biomarker for tracking the condition and ...

Restore Brain Highlights New Insights on How TMS Therapy Works Following Dallas Behavioral Health Summit

Restore Brain executive John Cavanagh shared neuroscience-based insights on TMS during a recent behavioral health summit held in Dallas Restore Brain Logo DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- ...
Business Insider

Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD

HOUSTON, TX, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the ...
AOL

Brain training game shows early promise for treating chronic pain without drugs

Researchers at the University of New South Wales Sydney are testing a new way to treat chronic nerve pain by training the brain itself. The approach relies on an interactive game that teaches people ...
UC San Francisco

If Anti-Seizure Meds Don’t Work for Epilepsy, Can Surgery Help?

Epilepsy is one of the most common neurological disorders, affecting 3.4 million Americans or 1 in 26 over a lifetime. The hallmark of epilepsy is seizures caused by abnormal bursts of electrical ...